BioConsortia Revenue

Biotechnology Research • Davis, California, United States • 21-50 Employees

BioConsortia revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$100,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$60,000,000

Key Contacts at BioConsortia

Marcus Meadows Smith

Ceo

Abhishek Patri

Director Of Process Development

Damian Curtis

Director Of Synthetic Biology And Genomics

Thomas Williams

Director Of Microbiology

Eunice Tan

Director Of Project Management

Graham Hymus

Director Of Plant Biology

Company overview

Headquarters	1940 Research Park Drive, Davis, CA 95618, US
Phone number	+15305645570
Website	bioconsortia.com
NAICS	541714
SIC	873
Keywords	Row Crops, Specialty Crops, Climate-Smart Agriculture, Plant-Microbe Interactions, Advanced Microbial Strain Development, Agricultural Input Innovation, Biocontrol Solutions For Crop Protection, Biofertilizers For Sustainable Agriculture, Bioinformatics & Data Science, Custom Microbial Solutions For Ag Companies, Microbial Discovery & Screening, Seed Treatment Microbials, Soil Health & Regenerative Agriculture, Sustainable Fertilizer Solutions, Synthetic Biology & Genomics
Founded	2014
Employees	21-50
Socials

BioConsortia Email Formats

BioConsortia uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@bioconsortia.com), used 66% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@bioconsortia.com	66%
{first name}{last name}	johndoe@bioconsortia.com	32%
{last name}{last name}	doedoe@bioconsortia.com	2%

About BioConsortia

BioConsortia, Inc. is revolutionizing agriculture with cutting-edge microbial solutions that boost plant health, increase yields, and promote sustainability. As leaders in gene editing and directed selection of microbes, BioConsortia harnesses the power of robust, spore-forming bacteria to develop innovative seed treatments and foliar products. The company’s proprietary Advanced Microbial Selection (AMS) process and GenePro genomics platform enable BioConsortia scientists to identify, design, and enhance microbes that help unlock the full potential of crop plants. From nitrogen-fixing microbes that reduce reliance on synthetic fertilizers to biopesticides and biostimulants that protect crops and improve resilience, BioConsortia delivers consistent, effective products that benefit growers and the environment.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

Manager

Employees by Department

BioConsortia has 28 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore BioConsortia's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-05-18	1	$15,000,000
2024-05-01	1	$15,000,000
2024-05-01	8	$15,000,000
2025-09-01	1	$15,000,000

Funding Insights

$60,000,000

Total funding amount

$15,000,000

Most recent funding amount

Number of funding rounds

BioConsortia Tech Stack

Discover the technologies and tools that power BioConsortia's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Astra

WordPress themes

Gravity Forms

Form builders

jQuery UI

JavaScript libraries

Beaver Builder

WordPress plugins

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

The Events Calendar

WordPress plugins

Frequently asked questions

BioConsortia is located in Davis, California, US.

You can reach BioConsortia at +15305645570.

BioConsortia generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

BioConsortia has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

BioConsortia was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

BioConsortia has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

BioConsortia has raised a total of $60,000,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at BioConsortia

Marcus Meadows Smith

Ceo

Abhishek Patri

Director Of Process Development

Damian Curtis

Director Of Synthetic Biology And Genomics

Thomas Williams

Director Of Microbiology

Eunice Tan